Analysis of the November 2000 Performance Evaluation Testing Results for Human T-lymphotropic Virus Types I and II Antibody
ثبت نشده
چکیده
This report is an analysis of results provided to the Centers for Disease Control and Prevention (CDC) by participant laboratories in the Model Performance Evaluation Program (MPEP) after they tested the human T-lymphotropic virus types I and II (HTLV-I/II) performance evaluation samples shipped to them in November 2000. Testing results for this analysis were provided by 189 (85.9%) of 220 laboratories sent sample panels. The testing results reported by the participant laboratories reflect their testing performance using manufactured kits to test performance evaluation samples and do not necessarily reflect an evaluation of these manufactured kits.
منابع مشابه
Analysis of the November 3, Performance Evaluation Testing Results for Human T-lymphotropic Virus Types I and II Antibody
This report is an analysis of results provided to the Centers for Disease Control and Prevention (CDC) by participant laboratories in the Model Performance Evaluation Program (MPEP) after they tested the human T-lymphotropic virus types I and II (HTLV-I/II) performance evaluation samples shipped to them on November 3, 1997. Testing results for this analysis were provided by 185 (96.9%) of 191 l...
متن کاملAnalysis of the May 15, 2000 Performance Evaluation Testing Results for Human T-lymphotropic Virus Types I and II Antibody
This report is an analysis of results provided to the Centers for Disease Control and Prevention (CDC) by participant laboratories in the Model Performance Evaluation Program (MPEP) after they tested the human T-lymphotropic virus types I and II (HTLV-I/II) performance evaluation samples shipped to them on May 15, 2000. Testing results for this analysis were provided by 204 (88.3%) of 231 labor...
متن کاملAnalysis of the May 5, 1997 Performance Evaluation Testing Results for Human T-lymphotropic Virus Types I and II Antibody
This report is an analysis of results provided to the Centers for Disease Control and Prevention (CDC) by participant laboratories in the Model Performance Evaluation Program (MPEP) after they tested the human T-lymphotropic virus types I and II (HTLV-I/II) performance evaluation samples shipped to them on May 5, 1997. Testing results for this analysis were provided by 185 (86.4%) of 214 labora...
متن کاملEvaluating the Frequency of Human T-Lymphotropic Virus Type 1 Infection in Iranian Population
Background: Human T-cell lymphotropic viruses 1 (HTLV1) is endemic in specific regions. We aimed to determine the prevalence of HTLV I infection among blood donors in southeast Iran. Methods: This cross-sectional study was conducted between April 2005 and March 2015. Sera were collected from blood donors and were tested for the presence of HTLV1 specific antibody using ELISA. Reactive sample...
متن کاملEvaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms.
To evaluate the usefulness of a human T-cell lymphotropic virus type I (HTLV-I) recombinant p21E immunoassay as a supplementary test in HTLV-I/II serologic testing algorithms, we used this assay to test 378 serum samples previously categorized as positive, indeterminant, or negative for HTLV-I/II antibody, as defined by U.S. Public Health Service guidelines. We found this test to be highly sens...
متن کامل